As of Aug 26
| +0.01 / +0.02%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 69.50, with a high estimate of 100.00 and a low estimate of 48.00. The median estimate represents a +18.26% increase from the last price of 58.77.
The current consensus among 26 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since August, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.